PATENT CLAIM ANALYSIS

Application Number: 15921322
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.

Claim (Index 3):
The method of  claim 2 , wherein the cancer is a solid cancer.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.17241
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15024215', '15877864', '15441103', '15449547', '15855507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6587700650068727
- 35 USC 102 Novelty (BERT): 0.6143656334719855
- Combined Prediction Score: 0.6543296218533841
- Mean Citation Score: 426.6234040000001
- Max Citation Score: 690.2668
- Similarity Product: 448.71183120508186

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test